Divanovic Lab


  • R01DK099222; Divanovic (PI); 08/2013-07/2018; “Immunopathogenesis of Non-alcoholic Fatty Liver Disease
  • R01DK099222-02S1; NIDDK Research Supplement to Promote Diversity in Health Related Research; Divanovic (PI), Moreno-Fernandez (Research Fellow); 08/2014-07/2016; “Immunopathogenesis of Non-alcoholic Fatty Liver Disease
  • Academic and Research Committee - Cincinnati Children's; Divanovic (Co-PI), Inge (Co-PI), Nakamura (Co-PI); 07/2015-06/2018; “Pediatric Diabetes and Obesity Center
  • Burroughs Wellcome Fund (1015032); Divanovic (PI); 07/2015-06/2019; “Role of type I IFNs/IFNAR axis in inflammation-induced preterm birth
  • Markham Family Award - Cincinnati Children's Hospital Medical Center Division of Gastroenterology, Hepatology and Nutrition; Divanovic (PI); 01/2016-12/2016; “Pathogenic potential of Th17 axis in NAFLD severity
  • Department of Defense (W81XWH-51-1-0370); Gandhi (PI); Divanovic (Co-I); 07/2015-06/2018; “Mechanisms of non-alcoholic steatohepatitis
  • New Investigator Scholar (NIS) awards; University of Cincinnati; Divanovic (PI), Giles (Student PI); 06/2014-05/2015; “Environmental regulation of transcriptional networks in inflammation
  • R21HL113907; Divanovic (PI); 04/2012-03/2015; “Better mouse models of disease: Humanizing experimental atherosclerosis
  • March of Dimes, Prematurity Research Initiative Grant; Dey (PI), Divanovic (Co-PI); 03/2012-02/2015; “Endocannabinoid signaling via CB2 protects against preterm birth by modulating immune responses